Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Lisa De Neve
MS
Lisa De Neve
Morgan Stanley
Wall Street Analyst
Not yet ranked — too few measurable calls.
100%
Success Rate
+11.5%
Average Return
2 of 2 calls profitable · +4.5% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 100% of Lisa De Neve's ratings turned a profit when each position was held for 1 year — averaging +11.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

15 Buy 38 Hold 3 Sell
Lisa's Stock Coverage 15 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
NL:DSFIR
DSM-Firmenich AG
 Jun 18, 2026 HOLD Hold
+0.6% avg upside
4 analysts
$73.00
5.22% Downside
 ·
CH:GIVN
Givaudan SA
 Jun 15, 2026 HOLD Buy
+9.9% avg upside
15 analysts
$2900.00
10.82% Downside
 ·
GB:KYGA
Kerry Group plc
 Jun 11, 2026 HOLD Strong Buy
+43.8% avg upside
7 analysts
$88.00
18.26% Upside
 ·
IFF
International Flavors & Fragrances
 May 29, 2026 BUY Strong Buy
+29.2% avg upside
27 analysts
$93.00
21.32% Upside
 +0.7%
ICL
Icl
 May 28, 2026 HOLD Hold
+21.8% avg upside
5 analysts
$5.80
12.85% Upside
 ·
GB:0O7D
Yara International
 Apr 27, 2026 HOLD Hold
+4.9% avg upside
9 analysts
$535.00
19.85% Upside
 ·
GB:TATE
Tate & Lyle
 Apr 01, 2026 SELL Buy
+4.0% avg upside
8 analysts
$375.00
32.22% Downside
 ·
GB:CRDA
Croda International
 Mar 25, 2026 BUY Strong Buy
+28.5% avg upside
9 analysts
$3350.00
7.51% Upside
 ·
DE:SY1
Symrise
 Jan 06, 2026 BUY Strong Buy
+23.1% avg upside
16 analysts
$102.00
19.19% Upside
 ·
CH:CLN
Clariant AG
 Jan 05, 2026 HOLD Buy
+55.7% avg upside
10 analysts
$8.30
9.43% Upside
 ·
DE:SDF
K+S Aktiengesellschaft
 Nov 28, 2025 HOLD Hold
+39.1% avg upside
9 analysts
$12.00
11.05% Downside
 ·
DE:WCH
Wacker Chemie AG
 Jul 05, 2024 HOLD Sell
-3.1% avg upside
10 analysts
$128.00
29.26% Upside
 ·
NL:OCI
OCI N.V.
 Apr 19, 2024 HOLD Buy
+348.7% avg upside
6 analysts
$27.50
645.67% Upside
 ·
DCF
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
 Nov 22, 2023 SELL Sell
+36876.7% avg upside
2 analysts
$3416.66
36876.72% Upside
 ·
GB:0NZR
Solvay SA
 Aug 11, 2021 BUY Buy
+96.9% avg upside
10 analysts
$129.00
371.06% Upside
 ·
🔒 10 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Lisa De Neve — Frequently Asked Questions
How accurate are Lisa De Neve's stock ratings?
Based on the calls 13Foresight could measure, about 100% of Lisa's ratings were profitable over a one-year hold, with an average return of +11.5% per rating, or +4.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Lisa ranked on 13Foresight?
Lisa De Neve is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Lisa cover?
Lisa most recently has ratings on NL:DSFIR, CH:GIVN, GB:KYGA, IFF, ICL, GB:0O7D, GB:TATE, GB:CRDA, DE:SY1, CH:CLN, DE:SDF, DE:WCH and 3 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.